Side-by-side comparison of AI visibility scores, market position, and capabilities
Amazon's pharmacy combining PillPack multi-medication pre-sorting with Prime prescription delivery; disrupting CVS and Walgreens with price transparency and same-day delivery in growing cities.
PillPack (now Amazon Pharmacy) is Amazon's full-service online pharmacy providing prescription delivery, medication management, and pharmacy services to US customers — originally founded as PillPack in 2013 by TJ Parker and Elliott Cohen to solve medication adherence for patients on multiple prescriptions, then acquired by Amazon in 2018 for $1 billion. Amazon has since rebranded the full-service pharmacy to Amazon Pharmacy while maintaining the PillPack brand for the multi-medication pre-sorting service for customers taking 5+ daily medications.\n\nPillPack's distinctive original service pre-sorts medications by dose and time (individual packets labeled "Monday 8AM: Take these 3 pills"), eliminating the confusion of managing multiple prescription bottles for patients with complex medication regimens. This packaging format particularly serves elderly patients and chronic disease patients taking 5-15 medications daily. Amazon Pharmacy (the broader service) provides standard prescription delivery with Prime shipping, price transparency through Amazon's prescription discount program, and pharmacist consultations.\n\nIn 2025, Amazon Pharmacy operates as a significant disruptor in the $350 billion US prescription market, competing with CVS Health (the largest pharmacy chain), Walgreens, Express Scripts (mail-order PBM pharmacy), and new pharmacy entrants like Ro, Alto Pharmacy, and Capsule. Amazon's advantages are its logistics infrastructure (Prime 2-day/same-day delivery), price comparison transparency, and consumer trust for e-commerce transactions. The 2025 strategy focuses on expanding same-day prescription delivery in more cities, growing specialty pharmacy capabilities for high-cost biologic medications, and integrating pharmacy with Amazon's broader health ecosystem (One Medical primary care, Amazon HealthLake health records).
NY digital health platform with owned pharmacy at $350M revenue in men's health, women's health, and GLP-1 weight management; $876M raised competing with Hims & Hers for DTC telehealth prescription delivery.
Ro is a New York-based digital health platform — backed with $876 million raised from General Catalyst, SignalFire, L Catterton, and others at a peak $7 billion valuation — providing telemedicine consultations, prescription management, and pharmacy-grade medication delivery for men's health (erectile dysfunction, hair loss under the Roman brand), women's health (fertility, menopause under the Rory brand), primary care (Ro Primary Care), and weight management (body program with GLP-1 medications). Founded in 2017 by Zachariah Reitano, Rob Schutz, and Saman Rahmanian, Ro generated approximately $350 million in revenue in 2024, serving over 2 million patients who have completed consultations through its platforms.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.